Your browser doesn't support javascript.
loading
Correction to: Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases.
Schoen, Martin W; Carson, Kenneth R; Eisen, Seth A; Bennett, Charles L; Luo, Suhong; Reimers, Melissa A; Knoche, Eric M; Whitmer, Alison L; Yan, Yan; Drake, Bettina F; Sanfilippo, Kristen M.
Afiliação
  • Schoen MW; Saint Louis Veterans Affairs Medical Center, Saint Louis, MO, USA. martin.schoen@health.slu.edu.
  • Carson KR; Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA. martin.schoen@health.slu.edu.
  • Eisen SA; Rush University, Chicago, IL, USA.
  • Bennett CL; Saint Louis Veterans Affairs Medical Center, Saint Louis, MO, USA.
  • Luo S; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Reimers MA; University of South Carolina College of Pharmacy, Columbia, SC, USA.
  • Knoche EM; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Whitmer AL; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Yan Y; Saint Louis Veterans Affairs Medical Center, Saint Louis, MO, USA.
  • Drake BF; Department of Medicine, Washington University School of Medicine, Saint Louis, MO, USA.
  • Sanfilippo KM; Saint Louis Veterans Affairs Medical Center, Saint Louis, MO, USA.
Prostate Cancer Prostatic Dis ; 26(4): 811, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37253974
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article